Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytotoxic impact of a perillyl alcohol–temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma in vitro
Catalina Silva‐Hirschberg, Hannah Hartman, Samantha Stack, et al.
Therapeutic Advances in Medical Oncology (2019) Vol. 11
Open Access | Times Cited: 11

Showing 11 citing articles:

Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development
Thomas C. Chen, Clóvis Orlando da Fonseca, Axel H. Schönthal
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3905-3905
Open Access | Times Cited: 73
Selected Monocyclic Monoterpenes and Their Derivatives as Effective Anticancer Therapeutic Agents
Mariola Zielińska‐Błajet, Przemysław Pietrusiak, Joanna Feder‐Kubis
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4763-4763
Open Access | Times Cited: 41
Vitamin C Supplementation in the Treatment of Autoimmune and Onco-Hematological Diseases: From Prophylaxis to Adjuvant Therapy
S. Isola, Luca Gammeri, Fabiana Furci, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7284-7284
Open Access | Times Cited: 7
Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme
Reena Jatyan, Prabhjeet Singh, Deepak Kumar Sahel, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 494-513
Closed Access | Times Cited: 26
Activation of Epstein–Barr Virus’ Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide
Hannah Hartman-Houstman, Steve Swenson, Radu O. Minea, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 936-936
Open Access | Times Cited: 4
Molecular pharmacology and therapeutic advances of monoterpene perillyl alcohol
Lulu Zhang, Guoguo Wang, Zehao Li, et al.
Phytomedicine (2024) Vol. 132, pp. 155826-155826
Closed Access | Times Cited: 2
NEO212, a Perillyl Alcohol-Temozolomide Conjugate, Triggers Macrophage Differentiation of Acute Myeloid Leukemia Cells and Blocks Their Tumorigenicity
Thomas C. Chen, Radu O. Minea, Steve Swenson, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6065-6065
Open Access | Times Cited: 9
Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice
Hee‐Yeon Cho, Steve Swenson, Thu Zan Thein, et al.
Neuro-Oncology Advances (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 11
Dracocephalum heterophyllum (DH) Exhibits Potent Anti-Proliferative Effects on Autoreactive CD4+ T Cells and Ameliorates the Development of Experimental Autoimmune Uveitis
Jiang Bian, Ke Wang, Qilan Wang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 6
Temozolomide-Loaded Solid Lipid Nanoparticles@Hydrogel for Local Treatment of Tumour
Weiwei Ji, Zhilan Liu
Australian Journal of Chemistry (2020) Vol. 74, Iss. 2, pp. 125-125
Closed Access | Times Cited: 3
Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia
Axel H. Schönthal, Steve Swenson, Radu O. Minea, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3385-3385
Open Access | Times Cited: 3
Page 1

Scroll to top